Gara Jalqabaatti › COPD › Arizona
Qorannoo klinikaalii COPD Arizona keessatti
Qorannoo 17 COPD f Arizona keessatti hirmaatuu jiru.
Magaalota Arizona keessatti
Takkalaa qorannoo (Ingiliffa)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Gilbert
- Research Site, Mesa
- Research Site, Mesa
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Tucson Clinical Research Institute- Site Number : 8400006, Tucson
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Banner University Medical Center Tucson, Tucson
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research - Phoenix, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Chandler Clinical Research Trials- Site Number : 8400025, Chandler
- Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix
- Epic Medical Research - Surprise- Site Number : 8400096, Surprise
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Banner University Medical Center, Phoenix
Namoota walitti qabaa jira
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Phoenix
- Research Site, Phoenix
- Research Site, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Arizona- Tuscon, Tucson
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Phoenix
- Research Site, Phoenix
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Phoenix
- Research Site, Scottsdale
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Chandler Clinical Trials, Chandler
- Pulmonary Associates, PA, Phoenix
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 35 hanga 80 · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 102, Phoenix
- GC2501 Study Site 107, Scottsdale
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07555483STRIVE Post-Market Registry Study
- Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT04302272SPIROMICS Study of Early COPD Progression (SOURCE)
- Mayo Clinic Arizona, Scottsdale
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 30 hanga 55 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05033990Pulmonary Rehabilitation for Rural Patients With COPD
- Mayo Clinic in Arizona, Scottsdale
Namoota walitti qabaa jira
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 07-Cam-2026 · NCT06847061Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Banner Health, Gilbert
Namoota walitti qabaa jira
Umuriin 40 hanga 84 · Saalaa hunda · Haaromfame 24-Elb-2026 · NCT06891755myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Honor Health, Scottsdale
Namoota walitti qabaa jira
Umuriin 30 fi ol · Saalaa hunda · Haaromfame 06-Gur-2025 · NCT05204888Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.